Skip to content
  • About Us
    • About Epigral
    • Our Core Ethos
    • Board of Directors
    • Our Journey
    • R&D
    • Corporate Brochure
  • Products
    • Chlor Alkali
    • Chloromethanes
    • Hydrogen Peroxide
    • Epichlorohydrin
    • CPVC
    • Chlorotoluenes Value Chain
    • Product Flow Chart
  • Sustainability
    • Certifications
    • Environment Health and Safety
    • Corporate Social Responsibility
    • Sustainability Reports
  • Investors
    • Results
    • Information on Shareholders
    • Financial Snapshot and Graphs
    • Shareholding Pattern
    • Rating Rationale
    • Governance, Policies & Compliances
    • FAQs
    • Key Contacts
  • Media
    • Digital Domain
    • Print Chronicles
    • Television Broadcasts
  • Careers
  • Contact us
  • About Us
    • About Epigral
    • Our Core Ethos
    • Board of Directors
    • Our Journey
    • R&D
    • Corporate Brochure
  • Products
    • Chlor Alkali
    • Chloromethanes
    • Hydrogen Peroxide
    • Epichlorohydrin
    • CPVC
    • Chlorotoluenes Value Chain
    • Product Flow Chart
  • Sustainability
    • Certifications
    • Environment Health and Safety
    • Corporate Social Responsibility
    • Sustainability Reports
  • Investors
    • Results
    • Information on Shareholders
    • Financial Snapshot and Graphs
    • Shareholding Pattern
    • Rating Rationale
    • Governance, Policies & Compliances
    • FAQs
    • Key Contacts
  • Media
    • Digital Domain
    • Print Chronicles
    • Television Broadcasts
  • Careers
  • Contact us
  • About Us
    • About Epigral
    • Our Core Ethos
    • Board of Directors
    • Our Journey
    • R&D
    • Corporate Brochure
  • Products
    • Chlor Alkali
    • Chloromethanes
    • Hydrogen Peroxide
    • Epichlorohydrin
    • CPVC
    • Chlorotoluenes Value Chain
    • Product Flow Chart
  • Sustainability
    • Certifications
    • Environment Health and Safety
    • Corporate Social Responsibility
    • Sustainability Reports
  • Investors
    • Results
    • Information on Shareholders
    • Financial Snapshot and Graphs
    • Shareholding Pattern
    • Rating Rationale
    • Governance, Policies & Compliances
    • FAQs
    • Key Contacts
  • Media
    • Digital Domain
    • Print Chronicles
    • Television Broadcasts
  • Careers
  • Contact us
  • About Us
    • About Epigral
    • Our Core Ethos
    • Board of Directors
    • Our Journey
    • R&D
    • Corporate Brochure
  • Products
    • Chlor Alkali
    • Chloromethanes
    • Hydrogen Peroxide
    • Epichlorohydrin
    • CPVC
    • Chlorotoluenes Value Chain
    • Product Flow Chart
  • Sustainability
    • Certifications
    • Environment Health and Safety
    • Corporate Social Responsibility
    • Sustainability Reports
  • Investors
    • Results
    • Information on Shareholders
    • Financial Snapshot and Graphs
    • Shareholding Pattern
    • Rating Rationale
    • Governance, Policies & Compliances
    • FAQs
    • Key Contacts
  • Media
    • Digital Domain
    • Print Chronicles
    • Television Broadcasts
  • Careers
  • Contact us

Digital Domain

Explore the digital sphere, where we connect and share our narratives, innovations and industry perspectives through online platforms.

Meghmani Finechem Limited’ is now ‘Epigral Limited’

  • 7 September 2023

Epigral expands into CPVC Compounding

  • 31 August 2023

Epigral Ltd announces expansion into CPVC compounds

  • 31 August 2023

Epigral to Set up Plant to Manufacture CPVC Compound

  • 31 August 2023

Meghmani Finchem commissions 18.34 MW wind-solar hybrid power plant

  • 28 June 2023

Meghmani Finechem shines on commissioning of wind-solar power plant

  • 28 June 2023

Mr. Maulik Patel, CMD, in talks with Moneycontrol, MFL business prospects and capex plans

  • 16 May 2023

Meghmani Finechem FY23 PAT up 40% at Rs. 353 Cr, revenue jumps 41% to Rs. 2,188 Cr

  • 27 April 2023

Meghmani Finech Consolidated March 2023 Net Sales at Rs 562.18 crore, up 12.71% Y-o-Y

  • 26 April 2023

Meghmani Finechem Ltd consolidated Q4 FY2023 PAT lower at Rs. 76.73 crores

  • 25 April 2023

Meghmani Finechem FY23 PAT Up 40% At Rs 353 Cr

  • 25 April 2023

Meghmani Finechem FY23 PAT up 40% at Rs. 353 Cr

  • 25 April 2023

Mr. Maulik Patel, CMD, in talks with CXO Today, Chemicals to take India’s growth to another level

  • 30 March 2023

Decoding China Plus One for the Indian chemical sector – Mr. Maulik Patel, CMD, Meghmani Fienchem Ltd

  • 22 January 2023

Meghmani Finechem’s Q3FY23 revenue up 27%; PAT by 11%

  • 20 January 2023

Meghmani Finechem Ltd reports Rs. 77.19 crores consolidated PAT in Q3FY23

  • 19 January 2023

Meghmani Finechem consolidated net profit rises 10.71% in the December 2022 quarter

  • 19 January 2023

Meghmani Finechem Board approves capacity expansion of CPVC Resin

  • 19 January 2023
Previous Page1 Page2 Page3 Page4 Page5 Page6 Next

Explore our solutions – Connect with Epigral

Important Links

  • Chlor Alkali
  • Chloromethanes
  • Hydrogen Peroxide
  • Epichlorohydrin
  • Chlorotoluenes Value Chain
  • CPVC
  • About Us
  • Chlor Alkali
  • Chloromethanes
  • Hydrogen Peroxide
  • Epichlorohydrin
  • Chlorotoluenes Value Chain
  • CPVC
  • About Us

Quick Links

  • Results
  • Our Journey
  • Environment Health and Safety
  • Corporate Social Responsibility
  • Careers
  • Contact us
  • Results
  • Our Journey
  • Environment Health and Safety
  • Corporate Social Responsibility
  • Careers
  • Contact us

Contact

Monday-Saturday: 08am-9pm
+91 79 29709600

Want to email us instead?
in**@*****al.com

At Epigral, we are at the forefront of India’s chemical industry, bringing solutions by providing essential derivatives and specialty chemicals.

© 2023 Copyrights Epigral Limited. All Rights Reserved.